hameln pharma is now also offering WFI and buffered solutions in bags, manufactured and filled in compliance with GMP regulations and thus suitable for processes from API development, to clinical studies phase I up to market supply.
For more information on this new service please see here.
::NAVI_NAME::
::NAVI_NAME::
News
hameln pharma extends portfolio 10.08.2010
Increased capacity due to new ampoule filling line 20.05.2010
Since 31st March hameln pharma possesses a new ampoule filling line and has thus increased its production capacity once more.
Without affecting daily production work the implementation of the new filling machine into hameln pharma´s new sterile production plant has been realised smoothly and shortly. The first terminally sterilised commercial batches will be manufactured on the line in July, only two months later the machine will be producing the complete range of products.
Thus the new ampoule filling line will provide on-going capacity and flexibility for our customers during the relocation of the last two lines from the existing building into the new sterile facility. Once the relocation has been completed the machine will secure further growth of the company.
Without affecting daily production work the implementation of the new filling machine into hameln pharma´s new sterile production plant has been realised smoothly and shortly. The first terminally sterilised commercial batches will be manufactured on the line in July, only two months later the machine will be producing the complete range of products.
Thus the new ampoule filling line will provide on-going capacity and flexibility for our customers during the relocation of the last two lines from the existing building into the new sterile facility. Once the relocation has been completed the machine will secure further growth of the company.